04/16/2024
3:11 PM | Spero Therapeutics (Filer)
| Form DEF 14A | |
04/16/2024
3:15 PM | Spero Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024
3:19 PM | Spero Therapeutics (Filer)
| Form ARS | |
03/29/2024
3:06 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2024
11:15 PM | Spero Therapeutics (Filer)
| Form EFFECT | |
03/15/2024
3:34 PM | Spero Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/15/2024
3:18 PM | Spero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/13/2024
3:07 PM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:10 PM | Spero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:25 PM | Anson Funds Management LP (Filed by)
Spero Therapeutics (Subject)
| Form SC 13G | |
02/05/2024
7:48 PM | JOSEPH TAMARA L (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:50 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:53 PM | Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:40 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:44 PM | Rajavelu Esther (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:45 PM | HAMED KAMAL (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:50 PM | Shukla Sath (Reporting)
Spero Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:07 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:11 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:40 PM | Spero Therapeutics (Issuer)
Tregoning Kathleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
7:13 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:45 PM | Spero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/01/2023
7:10 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
3:01 PM | Spero Therapeutics (Filer)
| Form 8-K/A | |
10/10/2023
4:34 PM | Deshpande Milind (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:39 PM | Spero Therapeutics (Issuer)
THOMAS FRANK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:40 PM | Smith Cynthia (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:43 PM | Pottage John C Jr (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:18 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:19 PM | Jackson Scott Thomas (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:28 PM | Spero Therapeutics (Issuer)
VINK PATRICK V.J.J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:29 PM | Spero Therapeutics (Issuer)
Tregoning Kathleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
7:28 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
4:47 PM | HAMED KAMAL (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:20 PM | Shukla Sath (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:21 PM | Mahadevia Ankit (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:22 PM | JOSEPH TAMARA L (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:23 PM | Keutzer Timothy (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
3:16 PM | Shukla Sath (Reporting)
Spero Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023
4:27 PM | Spero Therapeutics (Filer)
| Form PRE 14A | |
07/31/2023
7:12 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
07/24/2023
3:46 PM | DiPalma Stephen J. (Reporting)
Spero Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2023
7:30 AM | HAMED KAMAL (Reporting)
Spero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
7:12 AM | Spero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
